Scandinavian Journal of Haematology · 1985 · 11 citations · 14 references
Life SciencesHematologyImmunologyChemotherapyClinical ImmunologyImmunopathologyCell-mediated ImmunityHelper T Cell SubsetsT Cell ActivationT Cell BiologyT Cell DifferentiationCd4+ T Helper Cell ResponsesCd8 Positive T CellsHelper T Cell DifferentiationNatural Killer Cell PhenotypingProlymphocytic LeukemiaT Cell-mediated PathologyT Helper Cells
2 cases of T-cell prolymphocytic leukaemia (T-PLL) were investigated for their reactivity with a series of monoclonal antibodies (MoAbs) as well as for the cytochemical expression and functional activity of the pathological cells. Both patients showed morphological (large cells with abundant cytoplasm and eccentric and irregularly shaped nucleus with large and prominent nucleoli) and clinical (high leucocyte count and splenomegaly) features typical of T-PLL. The cells from 1 patient expressed a helper/inducer phenotype (T4+, T8-) and were reactive with the anti-Tac (interleukin-2 receptor) MoAb, while the other case co-expressed both the T4 and the T8 antigens. The response to phytohaemagglutinin and the natural killer activity (assessed by 51chromium release) were significantly reduced in both cases, while the helper capacity, tested in a pokeweed mitogen-driven system, was maintained only in the 1st case. This latter case which expressed a more mature phenotype (T4+, T8-) responded well to chemotherapy.
14
Takashi Uchiyama, S Broder, Thomas A. Waldmann · The Journal of Immunology · 1981 · 1.3K citations · Full text
D. A. G. Galton, J M Goldman, E. Wiltshaw et al. · British Journal of Haematology · 1974 · 422 citations
Medicine, Hematology, Pathology +14
T. A. Waldmann, Warner C. Greene, Prem S. Sarin et al. · Journal of Clinical Investigation · 1984 · 225 citations · Full text
Medicine, Hematology, Oncology +14
Characterization of a suppressor T-cell chronic lymphocytic leukemia with ADCC but not NK activity
F Pandolfi, D M Strong, R B Slease et al. · Blood · 1980 · 96 citations
Life Sciences, Immunology, Oncology +12